Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.
Expectant management is increasingly being used for patent ductus arteriosus in infants, but evidence to support this approach is limited. New research findings are summarized in a short video.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results